Patent · US Expired

3.beta.-(4-Oxo-.a lpha.-L-rhamnosyl)-.beta.-hydroxy-bufa-4,20,22-trienolide

US4031212A · kind A · utility

2Cited by

1References

3Claims

0Family size

Assignee

Boehringer Ingelheim GmbH · DE

Inventors

Walter Losel
Werner Traunecker · Münster-Sarmsheim, DE
Wolfgang Hoefke · Wiesbaden, DE

Key dates

Filing date	Jul 30, 1975
Grant date	Jun 21, 1977
Priority date	—
Expiry date	Jul 30, 1995

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07J19/005
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The compound of the formula ##STR1## which is useful as a cardiotonic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.